Literature DB >> 9696807

An enhanced packaging system for helper-dependent herpes simplex virus vectors.

T A Stavropoulos1, C A Strathdee.   

Abstract

Helper-dependent herpes simplex virus (HSV) vectors (amplicons) show considerable promise to provide for long-term transduced-gene expression in most cell types. The current packaging system of choice for these vectors involves cotransfection with a set of five overlapping cosmids that encode the full HSV type 1 (HSV-1) helper virus genome from which the packaging (pac) elements have been deleted. Although both the helper virus and the HSV amplicon can replicate, only the latter is packaged into infectious viral particles. Since the titers obtained are too low for practical application, an enhanced second-generation packaging system was developed by modifying both the helper virus and the HSV amplicon vector. The helper virus was reverse engineered by using the original five cosmids to generate a single HSV-bacterial artificial chromosome (BAC) clone in Escherichia coli from which the pac elements were deleted to generate a replication-proficient but packaging-defective HSV-1 genome. The HSV amplicon was modified to contain the simian virus 40 origin of replication, which acts as an HSV-independent replicon to provide for the replicative expansion of the vector. The HSV amplicon is packaged into infectious particles by cotransfection with the HSV-BAC helper virus into the 293T cell line, and the resulting cell lysate is free of detectable helper virus contamination. The combination of both modifications to the original packaging system affords an eightfold increase in the packaged-vector yield.

Entities:  

Mesh:

Year:  1998        PMID: 9696807      PMCID: PMC109935     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Herpes simplex virus for gene delivery to neurons.

Authors:  X O Breakefield; N A DeLuca
Journal:  New Biol       Date:  1991-03

2.  An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

Authors:  A I Geller; K Keyomarsi; J Bryan; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 3.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

4.  Isomerization of herpes simplex virus 1 genome: identification of the cis-acting and recombination sites within the domain of the a sequence.

Authors:  J Chou; B Roizman
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene.

Authors:  G R MacGregor; A E Mogg; J F Burke; C T Caskey
Journal:  Somat Cell Mol Genet       Date:  1987-05

6.  Persistence of freely replicating SV40 recombinant molecules carrying a selectable marker in permissive simian cells.

Authors:  L C Tsui; M L Breitman; L Siminovitch; M Buchwald
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

7.  Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants.

Authors:  E A Chiocca; B B Choi; W Z Cai; N A DeLuca; P A Schaffer; M DiFiglia; X O Breakefield; R L Martuza
Journal:  New Biol       Date:  1990-08

8.  A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.

Authors:  A I Geller; X O Breakefield
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

9.  A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture.

Authors:  T Paterson; R D Everett
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

10.  Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  A S Tischler; L A Greene
Journal:  Lab Invest       Date:  1978-08       Impact factor: 5.662

View more
  45 in total

1.  A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.

Authors:  G A Smith; L W Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 5.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 6.  Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents.

Authors:  Jacqueline N Parker; Xiaojia Zheng; William Luckett; James M Markert; Kevin A Cassady
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

Review 7.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

8.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

9.  Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

Authors:  Caryl E Sortwell; William J Bowers; Scott E Counts; Mark R Pitzer; Matthew F Fleming; Susan O McGuire; Kathleen A Maguire-Zeiss; Howard J Federoff; Timothy J Collier
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

10.  Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors.

Authors:  Rafael Nuñez; Cornel Fraefel; Mark Suter; Anne Nuñez-Liman; Hsiou-Chi Liou; Mathias Ackerman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.